-
Je něco špatně v tomto záznamu ?
Cardio-ankle vascular index in heterozygous familial hypercholesterolemia
Vladimir Soska, Petr Dobsak, Ladislav Dusek, Kohji Shirai, Jiri Jarkovsky, Marie Novakova, Petr Brhel, Jana Stastna, Lenka Fajkusova, Tomas Freiberger, Tomoyuki Yambe
Jazyk angličtina Země Japonsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS10096
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
Zdroj
NLK
Free Medical Journals
od 2002
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) - English
od 1994
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - English
od 1994
Open Access Digital Library
od 1994-01-01
Open Access Digital Library
od 2002-01-01
PubMed
22659529
DOI
10.5551/jat.9639
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- hyperlipoproteinemie typ II patofyziologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- srdce patofyziologie MeSH
- tlakový index kotník-paže MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
AIM: The cardio-ankle vascular index (CAVI) is a new non-invasive marker of arterial stiffness and atherosclerosis. The purpose of this study was to compare CAVI in patients with heterozygous familial hypercholesterolemia (FH) and in healthy controls. METHODS: 82 FH subjects (27 males, 65 females), aged 53.7±13.6 years without clinical symptoms of cardiovascular diseases and 359 healthy controls (121 males, 238 females), aged 43.9±14.9 years, were examined. CAVI was measured using the system VaSera® 1500. RESULTS: CAVI in FH patients was significantly higher (8.0±1.4) than in healthy subjects (7.5±1.3) p = 0.002; however, age, sex and BMI adjusted CAVI did not differ significantly (p = 0.061) between the FH group (7.5, CI: 7.3; 7.7) and control group (7.7, CI: 7.6; 7.7). CONCLUSION: The study showed no significant difference in CAVI between heterozygous FH and healthy controls.
2nd Clinic of Internal Medicine Masaryk University of Brno Czech Republic
Center of Molecular Biology and Gene Therapy University Hospital Brno Czech Republic
Department of Biochemistry Masaryk University of Brno Czech Rerpublic
Department of Physiology Faculty of Medicine Masaryk University of Brno Czech Republic
Internal Medicine Sakura Hospital Medical Center Toho University Chiba Japan
Molecular Genetics Laboratory Centre for Cardiovascular Surgery and Transplantation
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12034464
- 003
- CZ-PrNML
- 005
- 20160626101402.0
- 007
- ta
- 008
- 121023s2012 ja f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5551/jat.9639 $2 doi
- 035 __
- $a (PubMed)22659529
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ja
- 100 1_
- $a Soška, Vladimír, $d 1953- $7 nlk20020120980 $u 2nd Clinic of Internal Medicine, Masaryk University of Brno, Czech Republic; Department of Biochemistry, Masaryk University of Brno, Czech Rerpublic. vladimir.soska@fnusa.cz
- 245 10
- $a Cardio-ankle vascular index in heterozygous familial hypercholesterolemia / $c Vladimir Soska, Petr Dobsak, Ladislav Dusek, Kohji Shirai, Jiri Jarkovsky, Marie Novakova, Petr Brhel, Jana Stastna, Lenka Fajkusova, Tomas Freiberger, Tomoyuki Yambe
- 520 9_
- $a AIM: The cardio-ankle vascular index (CAVI) is a new non-invasive marker of arterial stiffness and atherosclerosis. The purpose of this study was to compare CAVI in patients with heterozygous familial hypercholesterolemia (FH) and in healthy controls. METHODS: 82 FH subjects (27 males, 65 females), aged 53.7±13.6 years without clinical symptoms of cardiovascular diseases and 359 healthy controls (121 males, 238 females), aged 43.9±14.9 years, were examined. CAVI was measured using the system VaSera® 1500. RESULTS: CAVI in FH patients was significantly higher (8.0±1.4) than in healthy subjects (7.5±1.3) p = 0.002; however, age, sex and BMI adjusted CAVI did not differ significantly (p = 0.061) between the FH group (7.5, CI: 7.3; 7.7) and control group (7.7, CI: 7.6; 7.7). CONCLUSION: The study showed no significant difference in CAVI between heterozygous FH and healthy controls.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a tlakový index kotník-paže $7 D055109
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a srdce $x patofyziologie $7 D006321
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperlipoproteinemie typ II $x patofyziologie $7 D006938
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dobšák, Petr, $d 1958- $7 xx0063744 $u Department of Sports Medicine and Rehabilitation, St. Anne's Faculty Hospital and Masaryk University of Brno, Czech Rerpublic
- 700 1_
- $a Dušek, Ladislav, $d 1967- $7 mzk2003181727 $u Institute of Biostatistics and Analyses, Faculty of Medicine and Faculty of Science, Masaryk University, Brno, Czech Rerpublic
- 700 1_
- $a Shirai, Kohji $u Internal Medicine, Sakura Hospital, Medical Center, Toho University, Chiba, Japan
- 700 1_
- $a Jarkovský, Jiří $7 stk2008461294 $u Institute of Biostatistics and Analyses, Faculty of Medicine and Faculty of Science, Masaryk University, Brno, Czech Rerpublic
- 700 1_
- $a Nováková, Marie, $d 1965- $7 xx0006795 $u Department of Physiology, Faculty of Medicine, Masaryk University of Brno, Czech Republic
- 700 1_
- $a Brhel, Petr, $d 1954- $7 mzk2005269713 $u Department of Occupational Medicine, St. Anne's Faculty Hospital and Masaryk University of Brno, Czech Republic
- 700 1_
- $a Šťastná, Jana $7 xx0104226 $u Children's Department of Internal Medicine, Faculty of Medicine, Masaryk University of Brno, Czech Republic
- 700 1_
- $a Fajkusová, Lenka, $d 1963- $7 xx0062747 $u Center of Molecular Biology and Gene Therapy, University Hospital Brno, Czech Republic
- 700 1_
- $a Freiberger, Tomáš $7 xx0071641 $u Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation
- 700 1_
- $a Yambe, Tomoyuki $u Department of Medical Engineering and Cardiology, Institute of Development, Aging and Cancer, Tohoku University
- 773 0_
- $w MED00008313 $t Journal of atherosclerosis and thrombosis $x 1880-3873 $g Roč. 19, č. 5 (2012), s. 453-461
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22659529 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20160626101546 $b ABA008
- 999 __
- $a ok $b bmc $g 956474 $s 791961
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 19 $c 5 $d 453-461 $i 1880-3873 $m Journal of atherosclerosis and thrombosis $n J Atheroscler Thromb $x MED00008313
- GRA __
- $a NS10096 $p MZ0
- LZP __
- $b NLK122 $a Pubmed-20121023